UMANG is powered by Niramai’s Thermalytix technology which uses a high resolution thermal sensing device and a cloud hosted analytics solution for analysing the thermal images. Thermalytix SaaS solution uses big data analytics, artificial intelligence and machine learning for reliable, early and accurate breast cancer screening. The innovative methods used in Thermalytix solution have led to multiple US patents. Novel algorithms have also been peer-reviewed in international scientific conferences.

Cancer screening tool, SMILE, has been tested on more than 400 patients data from 2 hospitals and one diagnostic center. Early results from these tests indicate very high accuracy that is comparable and sometime better that Mammography. 2 clinical trials have been started with established hospitals to perform large scale, statistically significant clinical trials.

SMILE is an interface for the user to upload the information about patient and thermal images. The information is processed using patented technology, Thermalytix, to analyse the breast health condition. This solution automatically generates a report listing the unique parameters obtained by this technology. Optionally, customers can choose an option for the certification of the report by a certified thermographer.

• A simple web based link for the user to access the tool.
• A separate interface for thermographer to view the patient information.
• Automated report generation with unique parameters generated by Thermalytix.
• Marking of potential abnormalities.
• Temperature display on hovering over the image.
• Certification from a experienced thermographer.
• Automated cropping for breast region segmentation.